BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18578619)

  • 1. Localization of concomitant metastases to kidney and erector spinae from papillary thyroid carcinoma using (131)I-SPECT and CT.
    Luo Q; Luo QY; Sheng SW; Chen LB; Yu YL; Lu HK; Zhu RS
    Thyroid; 2008 Jun; 18(6):663-4. PubMed ID: 18578619
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectus abdominis muscle metastasis from papillary thyroid cancer identified by I-131 SPECT/CT.
    Zhao LX; Li L; Li FL; Zhao Z
    Clin Nucl Med; 2010 May; 35(5):360-1. PubMed ID: 20395716
    [No Abstract]   [Full Text] [Related]  

  • 3. Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT.
    Qiu ZL; Luo QY
    Clin Nucl Med; 2009 Mar; 34(3):137-40. PubMed ID: 19352273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma.
    Panoussopoulos D; Theodoropoulos G; Vlahos K; Lazaris ACh; Papadimitriou K
    Int Surg; 2007; 92(4):226-9. PubMed ID: 18050833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
    Patel DR; Kamat BH; Farwell MD
    Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT.
    Sarma M; Sonik B; Subramanyam P; Sundaram PS
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):47-50. PubMed ID: 25698468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
    Malhotra G; Upadhye TS; Sridhar E; Asopa RV; Garde PS; Gawde S; Rangarajan V
    Clin Nucl Med; 2010 Sep; 35(9):731-6. PubMed ID: 20706057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan.
    Mechanick JI; Kim CK; Krynyckyi BR; Machac J; Urken ML
    Thyroid; 2000 Oct; 10(10):929-30. PubMed ID: 11081260
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal metastases from papillary thyroid carcinoma.
    Sardi A; Agnone CM; Pellegrini A
    J La State Med Soc; 1992 Sep; 144(9):416-20. PubMed ID: 1402321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal metastasis of thyroid carcinoma.
    Abe K; Hasegawa T; Onodera S; Oishi Y; Suzuki M
    Int J Urol; 2002 Nov; 9(11):656-8. PubMed ID: 12534914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.
    Yurkiewicz IR; Ganjoo KN; Iagaru A
    Clin Nucl Med; 2018 Apr; 43(4):e113-e114. PubMed ID: 29356736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unusual metastasis of differentiated thyroid carcinoma].
    Ferrer García JC; Merino Torres JF; Ponce Marco JL; Piñón Sellés F
    An Med Interna; 2002 Nov; 19(11):579-82. PubMed ID: 12522895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation.
    Borde C; Basu S; Kand P; Arya S; Shet T
    Hell J Nucl Med; 2011; 14(1):72-3. PubMed ID: 21512673
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple subdermal metastases from papillary thyroid cancer.
    Luo QY; Luo Q; Chen LB; Yu YL; Lu HK; Zhu RS
    Thyroid; 2008 Aug; 18(8):907-8. PubMed ID: 18690798
    [No Abstract]   [Full Text] [Related]  

  • 16. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.
    Smallridge RC; Castro MR; Morris JC; Young PR; Reynolds JC; Merino MJ; Sarlis NJ
    Thyroid; 2001 Aug; 11(8):795-804. PubMed ID: 11525275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous uptake of I-131 and F-18 FDG by a renal metastasis of thyroid papillary cancer.
    Oh JR; Lim JH; Jeong SY; Heo SH; Chong A; Min JJ
    Clin Nucl Med; 2011 Sep; 36(9):798-9. PubMed ID: 21825854
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
    Kohlfuerst S; Igerc I; Gallowitsch HJ; Gomez I; Kresnik E; Matschnig S; Lind P
    Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.